Cynthia collins

Our board of directors brings extensive expertise in pharmaceutical development, oncology, and healthcare operations to Panavance. His general management experience in the life science industry spans the pharmaceutical, biologics, biosurgery and medical device segments including acquisitions of public and private companies, private financings as well as taking a company public.

Prior to joining Panavance Greg was Chief Executive Officer of Geistlich Pharma North America where he led a cross functional team to achieve the market leadership position in regenerative medicine in the US dental field. Greg earned his B. James Brady is an experienced international business executive who served in multiple leadership roles of increasing responsibility for AstraZeneca prior to his retirement.

During his tenure at MedImmune, biologics grew to represent more than half of the product development portfolio of AstraZeneca and five biologics were successfully brought to market. His experience spans the full product development cycle from early research and clinical development to sales and product contracting. He holds a B.

Cynthia Cindy Collins, is a recognized leader in cell and gene therapy, genomic medicine, molecular diagnostics, life sciences, and therapeutics. Prior to Motorola, she spent seventeen years with Baxter Healthcare and six years with Abbott Laboratories.

Collins aerospace interiors

Marla Persky is CEO and President of WOMN LLC, a company dedicated to helping women succeed in the business of law by increasing their knowledge of and acuity with financial drivers, client development, and leadership. Additionally, she is on the Board of Directors of REVOLO Biotherapeutics which develops therapies to reset the immune system to achieve long-term remission for patients with autoimmune and allergic diseases.

In addition to her corporate activities, Ms. Erich Platzer brings expertise in financing startup companies focused on life sciences to Panavance. He has had multiple roles as chairman or board member of various biotech companies, public or private. Platzer spent 10 years at Roche development and business with his last position as therapeutic area head business oncology.

He was a medical faculty member at University of Erlangen, Germany since Dr.